0
0
12/11/22 at 12:14pm
Organization
Business Standard
Author
ANI
41 words
0
Comments
According to findings from the ADVANCE IV clinical trial patients taking efgartigimod a medication being studied for use to treat chronic primary ITP showed greater improvement in platelet counts
You are the first to view
https://www.business-standard.com/article/international/researchers-find-effective-drug-to-treat-autoimmune-itp-blood-disorder-122121100505_1.html
Create an account
or login to join the discussion